Citation

Németh Z, Kun B, Demetrovics Z. J. Psychopharmacol. 2010; 24(9): 1281-1287.

Affiliation

Eotvos Lorand University, Addiction Research Unit, Budapest and National Institute for Health Development, Budapest.

Copyright

(Copyright © 2010, SAGE Publishing)

DOI

10.1177/0269881110363315

PMID

20488831

Abstract

Over the past few years gamma-hydroxybutyrate (GHB) has generated widespread media interest as a possible 'date rape drug'. Our goal was to examine the extent to which GHB is associated with drug-facilitated sexual assaults. Literature was searched systematically and 11 studies, published between 1961 and June 30, 2009, were identified dealing specifically with the role of GHB in sexual assaults. GHB was detected in 0.2-4.4% of reported sexual assaults. The results demonstrate that a wide range of drugs may be present in cases of sexual assault, and many of them are much more frequent than GHB. Our results do not support the widespread labelling of GHB as a date rape drug as the prevalence of GHB is much lower than of other substances used in sexual assaults. On the other hand, however, the possible risk of GHB in this regard should not be neglected. Nevertheless, over-sensitive and sensation seeking media reports focusing on the association of sex crime and GHB might be counterproductive and misleading as they turn the attention away from other substances that are often used in sexual assaults.

Language: en